標(biāo)題: Titlebook: Clinical Psychopharmacology for Neurologists; A Practical Guide George T. Grossberg,Laurence J. Kinsella Book 2018 Springer International P [打印本頁(yè)] 作者: 民俗學(xué) 時(shí)間: 2025-3-21 16:11
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists影響因子(影響力)
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists被引頻次
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists被引頻次學(xué)科排名
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists年度引用
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists年度引用學(xué)科排名
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists讀者反饋
書(shū)目名稱(chēng)Clinical Psychopharmacology for Neurologists讀者反饋學(xué)科排名
作者: preservative 時(shí)間: 2025-3-21 20:26
Ulrike Olf,Peter Müller,Thomas Hohlfeldfirst step toward restoring mental and functional stability to a patient. In this chapter, an overview of the four generations of antipsychotics is provided for neurologists to enable them to initiate the treatment of psychosis in their neurological practice and refer the patient as needed for longe作者: Cubicle 時(shí)間: 2025-3-22 02:25
General Principles of Psychopharmacology,avigation less of a task of memorization and more of an exercise in concept practice. When encountering complex patients on multiple medications, it can be comforting to consult a clinical guide for reminders of important issues such as hepatic P450 metabolic route and need for laboratory monitoring作者: 吹牛需要藝術(shù) 時(shí)間: 2025-3-22 06:07 作者: Ambulatory 時(shí)間: 2025-3-22 11:45
https://doi.org/10.1007/978-3-319-74604-3Anticonvulsants, Antipsychotics, Sedative-hypnotics; Antidepressants, Anxiolytics, Mood stabilizers; C作者: SNEER 時(shí)間: 2025-3-22 13:01 作者: SNEER 時(shí)間: 2025-3-22 17:26
https://doi.org/10.1007/978-3-642-99548-4e patients with mood disorders, and many are comfortable prescribing a first-line agent such as an SSRI. In fact, a majority of mood disorders are treated by non-psychiatrists. Newer data shows the high prevalence of mood disorders in neurologic disease, such as Parkinson disease, stroke, and dement作者: 熄滅 時(shí)間: 2025-3-22 22:57
,Salben als Medikamententr?ger,ants, antipsychotics, and mood stabilizers were discovered to have efficacy in the 1950s, considerable efforts were taken to describe the pharmacology and neurobiology of psychiatric conditions and medications. With the exponential increase in knowledge of psychotropes, clinicians have had trouble s作者: 可觸知 時(shí)間: 2025-3-23 02:34 作者: ascend 時(shí)間: 2025-3-23 09:17 作者: 減震 時(shí)間: 2025-3-23 12:29 作者: cutlery 時(shí)間: 2025-3-23 14:10
Matthias Lütke Entrup,Dennis Goetjesof choice for decades. Benzodiazepines have shown the most evidence for effective treatment. However, they have serious side effects which include falls, confusion, rebound insomnia, tolerance, and potential for abuse. There have been newer medications that have sought to be just as effective withou作者: chandel 時(shí)間: 2025-3-23 21:26 作者: 柔軟 時(shí)間: 2025-3-24 01:59
Ulrike Olf,Peter Müller,Thomas Hohlfeldmental processes. Of all the psychiatric symptoms that neurological lesions can trigger, psychosis is perhaps the most confusing to the patient and alarming to the neurologist due to the seriousness of the symptoms that can range from delusions and hallucinations to bizarre behavior or harm to self 作者: 容易做 時(shí)間: 2025-3-24 06:06
Ulrike Olf,Peter Müller,Thomas Hohlfeldld decline in cognitive functioning, which gradually progresses to impairments across multiple cognitive domains and interference with daily activities. Treatment options across the spectrum from a mild neurocognitive disorder to the terminal stage of Alzheimer’s disease are discussed. Recommendatio作者: 寵愛(ài) 時(shí)間: 2025-3-24 08:34 作者: 賭博 時(shí)間: 2025-3-24 11:46 作者: adj憂(yōu)郁的 時(shí)間: 2025-3-24 16:08
https://doi.org/10.1007/978-3-658-02525-0r toxicity and drug interactions with the expanding use of herbal medications, OTCs, and dietary supplements. Clinicians need to be aware of potential drug interactions between prescribed and nonprescribed substances. It is important to take a thorough medication history that includes dietary habits作者: 期滿(mǎn) 時(shí)間: 2025-3-24 21:50
George T. Grossberg,Laurence J. KinsellaProvides neurologists with basic knowledge about psychiatric medications.Covers prescribing concerns specific to neurologists.Features relevant clinical cases and scenarios作者: PTCA635 時(shí)間: 2025-3-25 01:57
http://image.papertrans.cn/c/image/228200.jpg作者: 否決 時(shí)間: 2025-3-25 07:20
Psychopharmacology for Neurologists,e patients with mood disorders, and many are comfortable prescribing a first-line agent such as an SSRI. In fact, a majority of mood disorders are treated by non-psychiatrists. Newer data shows the high prevalence of mood disorders in neurologic disease, such as Parkinson disease, stroke, and dement作者: faultfinder 時(shí)間: 2025-3-25 07:43
General Principles of Psychopharmacology,ants, antipsychotics, and mood stabilizers were discovered to have efficacy in the 1950s, considerable efforts were taken to describe the pharmacology and neurobiology of psychiatric conditions and medications. With the exponential increase in knowledge of psychotropes, clinicians have had trouble s作者: 迷住 時(shí)間: 2025-3-25 14:59 作者: Abjure 時(shí)間: 2025-3-25 17:33
Antidepressants,tidepressant medication and depression-focused psychotherapy. All antidepressants are considered equally effective; therefore most clinicians select an agent based upon its side effect and safety profile. An antidepressant must be given at its therapeutic dose for 4–6?weeks before determining whethe作者: PANG 時(shí)間: 2025-3-25 22:06
Anxiolytics,e in their proper use. The mainstays of long-term treatment in any of the anxiety disorders are the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs). Acute treatment relies on benzodiazepines. Despite the effectiveness of the SSRIs and SNRIs, o作者: sorbitol 時(shí)間: 2025-3-26 03:37
Sedatives and Hypnotics,of choice for decades. Benzodiazepines have shown the most evidence for effective treatment. However, they have serious side effects which include falls, confusion, rebound insomnia, tolerance, and potential for abuse. There have been newer medications that have sought to be just as effective withou作者: 蟄伏 時(shí)間: 2025-3-26 07:54
Treating the Behavioral Symptoms of Dementia,ficant side effects and/or paucity of data limiting evidence-based guidance for the treating physician. Non-pharmacological interventions are first-line treatment for the behavior and psychological symptoms of dementia (BPSD). However, severe mood and behavioral changes often warrant pharmacological作者: Critical 時(shí)間: 2025-3-26 11:36 作者: 修飾語(yǔ) 時(shí)間: 2025-3-26 16:20 作者: Aphorism 時(shí)間: 2025-3-26 17:32
Drug-Drug Interactions and Psychiatric Medication,has been challenging to answer, often leading to using laborious drug interaction computer programs, smartphone-based programs, or a call to the pharmacist. The purpose of this chapter is to help address this question, assess the likelihood of a drug-drug interaction, and advise the patient on what 作者: myriad 時(shí)間: 2025-3-27 00:27
Mood Stabilizers, Anticonvulsants, and Anti-agitants,c disorders. Additionally, this chapter provides a focused overview of the management of adults with aggressive behaviors related to major psychiatric disorders, with an emphasis on conditions most likely to be encountered by neurologists. There are no FDA-approved pharmacological treatments of aggr作者: insurgent 時(shí)間: 2025-3-27 03:02
Drug-Dietary Interactions: Over-the-Counter Medications, Herbs, and Dietary Supplements,r toxicity and drug interactions with the expanding use of herbal medications, OTCs, and dietary supplements. Clinicians need to be aware of potential drug interactions between prescribed and nonprescribed substances. It is important to take a thorough medication history that includes dietary habits作者: obsolete 時(shí)間: 2025-3-27 06:23 作者: 險(xiǎn)代理人 時(shí)間: 2025-3-27 11:00
https://doi.org/10.1007/978-94-011-9420-4t-emergent akathisia, suicidality, or a hypomanic or manic episode. The use of antidepressants in specific neurological illnesses is also discussed. Self-report scales for measuring treatment responses are reviewed.作者: anaphylaxis 時(shí)間: 2025-3-27 15:46 作者: 猛烈責(zé)罵 時(shí)間: 2025-3-27 20:02 作者: 不能妥協(xié) 時(shí)間: 2025-3-28 00:43
Antidepressants,t-emergent akathisia, suicidality, or a hypomanic or manic episode. The use of antidepressants in specific neurological illnesses is also discussed. Self-report scales for measuring treatment responses are reviewed.作者: MULTI 時(shí)間: 2025-3-28 04:36 作者: 運(yùn)動(dòng)吧 時(shí)間: 2025-3-28 10:00 作者: Migratory 時(shí)間: 2025-3-28 10:36 作者: 費(fèi)解 時(shí)間: 2025-3-28 16:26 作者: Rejuvenate 時(shí)間: 2025-3-28 21:58
https://doi.org/10.1007/978-3-658-02525-0 drug interactions between prescribed and nonprescribed substances. It is important to take a thorough medication history that includes dietary habits, OTCs, supplements, and herbal remedies to predict and prevent potential interactions.作者: 新手 時(shí)間: 2025-3-29 00:04 作者: 代理人 時(shí)間: 2025-3-29 06:16 作者: 颶風(fēng) 時(shí)間: 2025-3-29 08:00 作者: Grievance 時(shí)間: 2025-3-29 15:19 作者: Cytology 時(shí)間: 2025-3-29 16:26
Treating the Behavioral Symptoms of Dementia, intervention requiring detailed risk/benefit analysis regarding medication choice. This chapter focuses on the clinical treatment of BPSD pertinent for the treating neurologist, providing a synopsis of the evidence supporting medication use and practical guidance on treatment selection, monitoring, and discontinuation.作者: 可憎 時(shí)間: 2025-3-29 21:31 作者: CAND 時(shí)間: 2025-3-30 03:30
Book 2018requency of?psychiatric illness?in neurology patients. It?goes?on to cover psychoactive drugs in the elderly?and?treating?behavioral?symptoms of dementia.? There is a special emphasis on drug-drug and drug-diet interactions that may be?seen in clinical practice.? Neurologists, residents, neuropsychi
